POAS
Phaos Technology Holdings (Caym
$1.70
+15.39%
2026-02-27
About Phaos Technology Holdings (Caym
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
Key Fundamentals
EPS (TTM)
$-0.27
ROE
-1073.1%
Revenue Growth (YoY)
-93.1%
Profit Margin
0.0%
Market Cap
$31.5M
Avg Volume (10D)
979K
Recent Breakout Signals
No recent breakout signals detected for POAS.
Recent Price Range (60 Days)
60D High
$7.39
60D Low
$0.53
Avg Volume
1.3M
Latest Close
$1.70
Get breakout alerts for POAS
Sign up for Breakout Scanner to receive daily notifications when POAS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Phaos Technology Holdings (Caym (POAS) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors POAS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. POAS operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.